Department of Clinical Imunology and Allergy, Faculty of Medical Sciences, UNICAMP, Campinas, Brazil. Background: Between 9.3 and 28.5% of world population are estimated to be allergic to the protein components of Hymenoptera venom and among them, the hyaluronidase (HYAL) is one of the most important, although the nature of its IgE binding epitopes is unknown. Methods: Enzyme was purified from P. paulista venom by cation exchange chromatography in AKTA-FPLC system with a Hiprep CM FF column. Fractions with HYAL activity were pooled, lyophilized, dialyzed against distilled water in presence of protease inhibitor (PMSF) and subjected to SDS-PAGE 15%. The only protein bands visualized were submitted to tryptic digestion and to MALDI-ToF/ToF mass spectrometry. Digested peptides produced were compared with partial/complete protein sequences from Data Bank including with the HYAL (Q9U6V9) of Polistes annularis venom used as model. Western blotting was performed with Pp-HYAL-specific antibody to test the identity of pure protein.
Results: All analysis performed identified the pure protein as an HYAL present in P.paulista venom, which also had its cDNA sequence (GI:302201582) cloned and determined in previous studies, being its high similarity with the Polistes annularis enzyme already confirmed. The mature allergenic protein has 338 amino acids and a molecular weight of 39 KDa. The same allergen is known in other insects, venoms and immunological cross reactivity may sometimes be observed among closely related species. Here, the immunoblotting assay revealed that the Pp-HYAL-specific antibody used recognized the correspondent protein in the purified fraction and in the crude venom of P. paulista, but not in the Apis mellifera and Solenopsis invicta venoms. Conclusions: The methodology used was able to purify the allergen, which is a key step in the characterization of its binding epitopes. Such knowledge has direct implications in accuracy of diagnostic procedures and strategies for specific immunotherapy of allergic patients to the venom of this insect. Funding: Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP). Background: Induction of long-term tolerance towards Phl p 5 was previously achieved by transplantation of hematopoetic stem cells (HSCs) genetically modified to express membrane-bound Phl p 5 allergen. To facilitate the further development of tolerogenic cell therapies for allergy, a transgenic mouse expressing Phl p 5 ubiquitously as membrane-anchored protein, was generated. Here we investigated the immunogenicity of the membrane-anchored version of Phl p 5. Methods: The Phl p 5-transgenic mouse (Balb/c background) was generated by pronuclear injection integrating Phl p 5 fused to a leader peptide and a transmembrane domain under control of a CMV-promotor with a GFPreporter. Splenocytes (2.5 · 10 6 per mouse), cell extracts containing mainly membrane proteins and recombinant (r) Phl p 5 [5 mg1/2 Al(OH) 3 per mouse] were injected subcutaneously into naïve Balb/c mice (n ¼ 8 per group). The amount of Phl p 5 of splenocytes and cell extracts was semiquantitatively determined via western blotting. Furthermore skin of Phl p 5-transgenic mice was grafted onto naïve Balb/c (n ¼ 13 in 2 independent experiments), a rejection model in allo-transplantation since skin is highly immunogenic and therefore readily rejected. Phl p 5-specific antibody response was determined in sera by ELISAs. For T-cell responses splenocyte-proliferation was assessed in vitro after stimulation with rPhl p 5. Results: Surprisingly, a prompt rejection (within 8-10 days) was elicited, accompanied by a strong Phl p 5 specific antibody response including Phl p 5-specific IgE in wildtype Balb/c after skin rejection of Phl p 5-transgenic mice. Additionally to the skin grafted group, mice receiving splenocytes or rPhl p 5 plus adjuvant showed a comparable response in matters of Phl p 5-specific IgE-and IgG1-levels through the whole follow-up (week 1, 2, 3, 5, 7, 9, 11) suggesting an unusually strong immune response to cell or tissue-bound Phl p 5. Furthermore Phl p 5-specific IgG2a/2b/3, IgA and IgM were induced. Besides in vitro splenocyte-proliferation assays showed Phl p 5 specific T-cell responses in all groups of mice that showed strong humoral responses. Background: Only a limited number of proteins have the potential to induce Th2-polarized immune responses and specific IgE in genetically predisposed individuals. However, why the contact with an allergen results either in allergic sensitization or tolerance induction has remained unclear so far. Here, we focused on the in depth study of uptake, induction of signal transduction pathways, and gene regulation in monocyte-derived dendritic cells (MoDCs) of allergic and normal individuals in response to the major birch pollen (BP) allergen Bet v 1.0101 and its structural homolog from celery, Api g 1.0101. Methods: Live cell fluorescence microscopy was used to analyze uptake kinetics, competitive binding, and internalization pathways of labeled allergens by iMoDCs. To delineate allergen-mediated gene activation, iMoDCs were incubated with the allergens, a control stimulus, or left untreated followed by real-time PCR-based gene expression profiling. Surface-bound IgE was detected by immunofluorescence microscopy and IgE-mediated gene activation by real-time PCR. Results: Comparable kinetics of Bet v 1.0101 and Api g 1.0101 uptake were observed for both allergic and healthy donors. In competititve binding assays, however, Bet v 1.0101 outcompeted Api g 1.0101 for surface recognition in both donor groups. Pharmacological inhibition evidenced that Bet v 1.0101 internalization occurred in a receptor-mediated manner showing characteristics of lipid raft-dependent endocytosis. MoDCs of both donor groups were IgE positive and showed marked upregulation in NF-kB dependent genes after Fce receptor activation by anti-IgE. Bet v 1.0101-stimulation, in contrast, exclusively triggered transcription of the Th2 cytokines IL-4 and IL-13
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